drugset / Trial / NCT00271518

Treatment of Children With Insufficient Secretion of Growth Hormone

NCT00271518

Phase 3 Unknown 144 enrolled LG Life Sciences BioPartners GmbH · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare a new weekly administered growth hormone preparation with standard daily treatment in children with insufficient secretion of growth hormone

Timeline

Start
2005-09
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic

Indications

No indication recorded.